title: Reply by authors.
authors.forename: S
authors.initials: S
authors.lastname: Maru
authors.forename: Y
authors.initials: Y
authors.lastname: Ishigaki
authors.forename: N
authors.initials: N
authors.lastname: Shinohara
authors.forename: T
authors.initials: T
authors.lastname: Takata
authors.forename: N
authors.initials: N
authors.lastname: Tomosugi
authors.forename: K
authors.initials: K
authors.lastname: Nonomura
mesh_terms: D051792:Basic Helix-Loop-Helix Proteins / Q000096:biosynthesis*; D015820:Cadherins / Q000096:biosynthesis*; D002292:Carcinoma, Renal Cell / Q000378:metabolism* / Q000473:pathology*; D002465:Cell Movement; D006801:Humans; D007680:Kidney Neoplasms / Q000378:metabolism* / Q000473:pathology*; D046912:Multiprotein Complexes / Q000037:antagonists & inhibitors*; D011506:Proteins / Q000037:antagonists & inhibitors*; D058570:TOR Serine-Threonine Kinases / Q000037:antagonists & inhibitors*; D015854:Up-Regulation
chemical_list: D051792:Basic Helix-Loop-Helix Proteins; D015820:Cadherins; D046912:Multiprotein Complexes; D011506:Proteins; D058570:TOR Serine-Threonine Kinases